Bioceltix S.A. (BCX)
GPW
80.00
-0.90 (-1.11%)
Closed
Aug 21, 2026
Day's Range
79.1080.90
52 wk Range
70.00108.00
Financial Statements - BCX - Bioceltix S.A.
Revenue
0
Net Income
-15.15M▼ 1.8%
EBITDA
-14.26M▼ 0.6%
Free Cash Flow
-13.91M▲ 21.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 10.80K |
| Cost of Goods | 2.04M | 1.42M | 1.03M | 699.99K | 853.86K | 478.54K |
| Gross Profit | -2.04M | -1.42M | -1.03M | -699.99K | -853.86K | -467.74K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -15.15M | -15.08M | -14.01M | -8.95M | -4.40M | -2.37M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -15.17M | -14.86M | -13.69M | -8.96M | -4.35M | -2.36M |
| Income Tax | -15.38K | 30.52K | -5.26K | -46.10K | 41.51K | -17.03K |
| Net Income | -15.15M | -14.89M | -13.68M | -8.92M | -4.39M | -2.34M |
| EPS Basic | -3.03 | -3.28 | -3.49 | -2.67 | -1.39 | -0.95 |
| EPS Diluted | -3.03 | -3.28 | -3.49 | -2.67 | -1.39 | -0.95 |
| Basic Shares Outstanding | 4.99M | 4.53M | 3.91M | 3.33M | 3.16M | 3.28M |
| Diluted Shares Outstanding | 4.99M | 4.53M | 3.91M | 3.33M | 3.16M | 3.28M |
| Ebit | -15.02M | -14.69M | -13.65M | -8.93M | -4.33M | -2.34M |
| Ebitda | -14.26M | -14.17M | -13.22M | -8.54M | -4.02M | -2.12M |
| Net Income Continuous Operations | -15.15M | -14.89M | -13.68M | -8.92M | -4.39M | -2.43M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
